c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
BioAge (BIOA) Reports Q3 Revenue Miss, Focuses on Oral Anti-Inflammatory Drug Development
GuruFocus | Nov 5, 2026 6:51 PM EST
Related Stocks: BIOA ,
Read original article